A microengineered pathophysiological model of early-stage breast cancer
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
We report a microengineered cell culture platform that reconstitutes the 3D architecture and microenvironment of early-stage breast cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This model system enabled the establishment of physiologically relevant tissue architectures, the location of micro-environmental cues, and a direct observation of cell responses.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [34]
In the citing paper
“In recent years, techniques which can overcome the abnormal vasculature in the tumor, such as nanoparticle drug delivery and drugs normalizing vascular network, were shown to be able to greatly improve anti-cancer treatment [108-113].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [109]
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
A tense situation: forcing tumour progression
Butcher, D. T., Alliston, T., & Weaver, V. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2544 · Cited by 1,940
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Self-citationModeling tissue-specific signaling and organ function in three dimensions
Schmeichel, K. L., & Bissell, M. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00503 · Cited by 585
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines
Liebmann, J., Cook, J., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.488 · Cited by 428
The microenvironment in breast cancer progression: biology and implications for treatment
Place, A. E., Jin Huh, S., & Polyak, K. (2011) · Breast Cancer Research · doi:10.1186/bcr2912 · Cited by 413
Lyons, T. R., O'Brien, J., Borges, V. F., Conklin, M. W., Keely, P. J., Eliceiri, K. W., Marusyk, A., Tan, A.-C., & Schedin, P. (2011) · Nature Medicine · doi:10.1038/nm.2416 · Cited by 380
Cited by
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Hassell, B. A., Goyal, G., Lee, E., Sontheimer-Phelps, A., Levy, O., Chen, C. S., & Ingber, D. E. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.043 · Cited by 467
“, growth, migration, invasion, angiogenesis, extravasation, and drug effects) (Choi et al., 2015; Skardal et al., 2015; Portillo-Lara and Annabi, 2016), none of these recapitulate complex organ-level patterns of cancer growth or therapeutic responses seen in patients.”
BackgroundSelf-citationOrgan-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Application of microfluidic chip technology in pharmaceutical analysis: A review
Cui, P., & Wang, S. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.12.001 · Cited by 390
Letai, A., Bhola, P., & Welm, A. L. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.004 · Cited by 281
Recent advances in microfluidic technologies for cell-to-cell interaction studies
Rothbauer, M., Zirath, H., & Ertl, P. (2018) · Lab on a Chip · doi:10.1039/c7lc00815e · Cited by 277
Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing
Yang, X., Li, K., Zhang, X., Liu, C., Guo, B., Wen, W., & Gao, X. (2018) · Lab on a Chip · doi:10.1039/c7lc01224a · Cited by 240
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
Caballero, D., Kaushik, S., Correlo, V. M., Oliveira, J. M., Reis, R. L., & Kundu, S. C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.005 · Cited by 221
Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment
Tsai, H.-F., Trubelja, A., Shen, A. Q., & Bao, G. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0137 · Cited by 214
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Testa, U., Castelli, G., & Pelosi, E. (2020) · Medical Sciences · doi:10.3390/medsci8010018 · Cited by 214
Breast cancer models: Engineering the tumor microenvironment
Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X., & Zorlutuna, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.006 · Cited by 213
Trujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
“co-cultured breast spheroids (MCF10-DCIS), HMFs, and human mammary epithelial cells (HMT-3522; S1) embedded in a collagen type I-hydrogel to replicate the microarchitecture of DCIS in a tumor-on-chip (Figure 5c-i) [34].”
MethodParlato, S., De Ninno, A., Molfetta, R., Toschi, E., Salerno, D., Mencattini, A., Romagnoli, G., Fragale, A., Roccazzello, L., Buoncervello, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01013-x · Cited by 181
Khoo, B. L., Grenci, G., Lim, Y. B., Lee, S. C., Han, J., & Lim, C. T. (2018) · Nature Protocols · doi:10.1038/nprot.2017.125 · Cited by 172
Self-citationMultiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges
Wang, Y. I., Carmona, C., Hickman, J. J., & Shuler, M. L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701000 · Cited by 167
Microwave Sensors for Breast Cancer Detection
Wang, L. (2018) · Sensors · doi:10.3390/s18020655 · Cited by 170
Heralding a new paradigm in 3D tumor modeling
Fong, E. L. S., Harrington, D. A., Farach-Carson, M. C., & Yu, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.052 · Cited by 155
Wang, J., Li, B., Luo, M., Huang, J., Zhang, K., Zheng, S., Zhang, S., & Zhou, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01779-3 · Cited by 191
Cell spheroids: the new frontiers in in vitro models for cancer drug validation
Chatzinikolaidou, Μ. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.024 · Cited by 145
Cancer-on-a-chip systems at the frontier of nanomedicine
Zhang, Y. S., Zhang, Y.-N., & Zhang, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.011 · Cited by 127
Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment
Portillo-Lara, R., & Annabi, N. (2016) · Lab on a Chip · doi:10.1039/c6lc00718j · Cited by 127
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
“DCIS cell spheroids introduced on the epithelial side of the membrane integrated with the epithelium, did not invade the stromal layer, and were sensitive to the chemotherapy paclitaxel (normal mammary epithelial cells showed no chemotoxicity) [70].”
BackgroundDigital Light Processing Bioprinting Advances for Microtissue Models
Hosseinabadi, H. G., Dogan, E., Miri, A. K., & Ionov, L. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01509 · Cited by 144
Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches
Sleeboom, J. J. F., Eslami Amirabadi, H., Nair, P., Sahlgren, C. M., & den Toonder, J. M. J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033100 · Cited by 122
“3J (Choi et al., 2015).”
Gioiella, F., Urciuolo, F., Imparato, G., Brancato, V., & Netti, P. A. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600772 · Cited by 112
Developmentally inspired human ‘organs on chips’
Ingber, D. E. (2018) · Development · doi:10.1242/dev.156125 · Cited by 124
“For example, fibroblasts have been integrated in a model of early stage human breast cancer (Choi et al., 2015).”
BackgroundCancer Modeling‐on‐a‐Chip with Future Artificial Intelligence Integration
Fetah, K., DiPardo, B. J., Kongadzem, E.-M. L., Tomlinson, J. S., Elzagheid, A. I., Elmusrati, M. S., Khademhosseini, A., & Ashammakhi, N. A. (2019) · Small · doi:10.1002/smll.201901985 · Cited by 121
Multi-material digital light processing bioprinting of hydrogel-based microfluidic chips
Bhusal, A., Dogan, E., Nguyen, H.-A., Labutina, O., Nieto, D., Khademhosseini, A., & Miri, A. K. (2021) · Biofabrication · doi:10.1088/1758-5090/ac2d78 · Cited by 134
“The vascular models, such as double-layer stacked microchannels (figure 4(B-iv)), can be used for multi-culture micro-tissue models [73, 74].”
From 2D to 3D Cancer Cell Models—The Enigmas of Drug Delivery Research
Van Zundert, I., Fortuni, B., & Rocha, S. (2020) · Nanomaterials · doi:10.3390/nano10112236 · Cited by 107
“To better resemble the physiological microenvironment of cancer in the human body, the microfluidic devices (so-called tumor-on-chip) can, in addition to the cancer cells, endothelial cells and ECM, also incorporate other cell types found in the tumor stroma, namely fibroblasts and immune cells [141].”
BackgroundThe intercell dynamics of T cells and dendritic cells in a lymph node-on-a-chip flow device
Moura Rosa, P., Gopalakrishnan, N., Ibrahim, H., Haug, M., & Halaas, Ø. (2016) · Lab on a Chip · doi:10.1039/c6lc00702c · Cited by 106
Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine
Chen, X., Zhang, Y. S., Zhang, X., & Liu, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.09.022 · Cited by 107
“lung [68,69], liver [70,71], blood vessel [72,73], gut [74,75], heart [76,77], uterus [78,79], brain [80–82], bone marrow [83,84], and tumor/cancer [85,86], as illustrated in Scheme 1.”
BackgroundA Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Pradhan, S., Smith, A. M., Garson, C. J., Hassani, I., Seeto, W. J., Pant, K., Arnold, R. D., Prabhakarpandian, B., & Lipke, E. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-21075-9 · Cited by 96
Spheroid Engineering in Microfluidic Devices
Tevlek, A., Keçili, S., Ozcelik, O. S., Külah, H., & Tekin, H. C. (2023) · ACS Omega · doi:10.1021/acsomega.2c06052 · Cited by 104
Mondrinos, M. J., Yi, Y.-S., Wu, N.-K., Ding, X., & Huh, D. (2017) · Lab on a Chip · doi:10.1039/c7lc00317j · Cited by 95
Self-citationTissue Engineering and Regenerative Medicine 2015: A Year in Review
Wobma, H., & Vunjak-Novakovic, G. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0535 · Cited by 92
“For example, in their Nature article (63), Choi et al.”
BackgroundSeo, S., Nah, S.-Y., Lee, K., Choi, N., & Kim, H. N. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106860 · Cited by 94
Self-citationMicrofluidic co-culture system for cancer migratory analysis and anti-metastatic drugs screening
Mi, S., Du, Z., Xu, Y., Wu, Z., Qian, X., Zhang, M., & Sun, W. (2016) · Scientific Reports · doi:10.1038/srep35544 · Cited by 83
Dhiman, N., Kingshott, P., Sümer, H., Sharma, C. S., & Rath, S. N. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.02.070 · Cited by 90
Integration of Extracellular Matrices into Organ‐on‐Chip Systems
Kutluk, H., Bastounis, E. E., & Constantinou, I. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203256 · Cited by 84
Microfluidic lumen-based systems for advancing tubular organ modeling
Virumbrales-Muñoz, M., Ayuso, J. M., Gong, M. M., Humayun, M., Livingston, M. K., Lugo-Cintrón, K. M., McMinn, P., Álvarez-García, Y. R., & Beebe, D. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00705f · Cited by 76
Microfluidic technologies for anticancer drug studies
Valente, K. P., Khetani, S., Kolahchi, A. R., Sanati‐Nezhad, A., Suleman, A., & Akbari, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.010 · Cited by 78
PI3K functions as a hub in mechanotransduction
Di-Luoffo, M., Ben-Meriem, Z., Lefebvre, P., Delarue, M., & Guillermet-Guibert, J. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.05.005 · Cited by 74
Organ on Chip Technology to Model Cancer Growth and Metastasis
Imparato, G., Urciuolo, F., & Netti, P. A. (2022) · Bioengineering · doi:10.3390/bioengineering9010028 · Cited by 82
“Reproduced from [14] with permission from The Royal Society of”
BackgroundMethodMimicking Human Pathophysiology in Organ‐on‐Chip Devices
Yeşil-Çeliktaş, Ö., Hassan, S., Miri, A. K., Maharjan, S., Al‐kharboosh, R., Quiñones‐Hinojosa, A., & Zhang, Y. S. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800109 · Cited by 80
Multifunctional microfluidic chip for cancer diagnosis and treatment
Guo, Q., Zhang, L.-L., Liu, J., Li, Z., Li, J.-J., Zhou, W., Wang, H., Li, J., Liu, D., Yu, X., et al. (2020) · Nanotheranostics · doi:10.7150/ntno.49614 · Cited by 81
“Lesions of ductal carcinoma in situ 3D culture Breast cancer Tumor spheroid co-cultured with mammary fibroblasts and human mammary ductal epithelial cells to mimic 3D structural organization and microenvironment [169]”
BackgroundBreast tumor-on-chip models: From disease modeling to personalized drug screening
Bano, S., Dahiya, U. R., Mishra, S., Ayache, J., Casquillas, G. V., Caballero, D., Reis, R. L., & Kundu, S. C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.057 · Cited by 83
Organ-on-a-Chip Platforms for Drug Screening and Delivery in Tumor Cells: A Systematic Review
Gonçalves, I. M., Carvalho, V. M., Rodrigues, R. O., Pinho, D., Teixeira, S., Moita, A., Hori, T., Kaji, H., Lima, R. A., & Minas, G. M. H. (2022) · Cancers · doi:10.3390/cancers14040935 · Cited by 81
“Several authors have sought to replicate not only the tumor microenvironment but also specific characteristics of the system that was being reproduced, as described in [28,62,76].”
BackgroundStadler, M., Walter, S., Walzl, A., Kramer, N., Unger, C., Scherzer, M., Unterleuthner, D., Hengstschläger, M., Krupitza, G., & Dolznig, H. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.007 · Cited by 82
Design and engineering of organ-on-a-chip
Cho, S., Lee, S., & Ahn, S. I. (2023) · Biomedical Engineering Letters · doi:10.1007/s13534-022-00258-4 · Cited by 78
“Collagen gel has been widely used to mimic the physiological environment of tumors in OOC devices, including a colorectal model [16] and a platform for studying breast ductal carcinoma [42].”
MethodSelf-citationBhuskute, H., Shende, P. K., & Prabhakar, B. R. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02153-0 · Cited by 77
“The micro-engineered model simulating tumour’s pathophysiology shows potential in accurately providing drug toxicity and efficacy results (75) AAPS PharmSciTech (2022) 23: 8 8 Page 6 of 12”
BackgroundRecent Advances in Microfluidic Platforms for Programming Cell‐Based Living Materials
Zhang, P., Shao, N., & Qin, L. (2021) · Advanced Materials · doi:10.1002/adma.202005944 · Cited by 63
Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00531c · Cited by 58
A 3D Microfluidic Model to Recapitulate Cancer Cell Migration and Invasion
Toh, Y.-C., Raja, A., Yu, H., & Van Noort, D. (2018) · Bioengineering · doi:10.3390/bioengineering5020029 · Cited by 57
“It should also be noted that cancer cell density influences the cell migration [25,26].”
BackgroundRecent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 63
Chi, C., Lao, Y., Ahmed, A. H. R., Benoy, E. C., Li, C., Dereli‐Korkut, Z., Fu, B. M., Leong, K. W., & Wang, S. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000880 · Cited by 64
Kutys, M. L., Polacheck, W. J., Welch, M., Gagnon, K. A., Koorman, T., Kim, S., Li, L., McClatchey, A. I., & Chen, C. S. (2020) · Nature Communications · doi:10.1038/s41467-020-17102-x · Cited by 60
Collagen I Based Enzymatically Degradable Membranes for Organ-on-a-Chip Barrier Models
Arık, Y. B., Vivas, A., Laarveld, D., van Laar, N., Gemser, J., Visscher, T., van den Berg, A., Passier, R. C., & van der Meer, A. D. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00297 · Cited by 59
“47 Because of its potency in tissue dissociation, we exposed the membranes to relatively low concentrations (24, 48, or 120 U/mL) for a short duration of 5 min.”
3D modeling of cancer stem cell niche
He, J., Xiong, L., Li, Q., Lin, L., Miao, X., Yan, S., Hong, Z., Yang, L., Wen, Y., & Deng, X. (2017) · Oncotarget · doi:10.18632/oncotarget.19847 · Cited by 64
“To investigate tumor progression, a biomimetic microengineering approach is developed based on 3D microsystem principles [171].”
MethodModeling organ-specific vasculature with organ-on-a-chip devices
Lin, D. S. Y., Guo, F., & Zhang, B. (2018) · Nanotechnology · doi:10.1088/1361-6528/aae7de · Cited by 61
“chip [20, 21], glomerulus-on-a-chip [22], blood–brain barrier (BBB)-on-a-chip [23], vessel-on-a-chip [24], blinking eye-ona-chip [25], and cancer-on-a-chip [26], etc.”
Simitian, G. S., Virumbrales-Muñoz, M., Sánchez‐de‐Diego, C., Beebe, D. J., & Kosoff, D. (2022) · Lab on a Chip · doi:10.1039/d2lc00352j · Cited by 56
The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
Fröhlich, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087116 · Cited by 57
Cavero, I., Guillon, J., & Holzgrefe, H. H. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1634689 · Cited by 53
“[81,83,84]) which should be consulted for detailed information.”
BackgroundHuman Organs‐on‐Chips: A Review of the State‐of‐the‐Art, Current Prospects, and Future Challenges
Zarrintaj, P., Saeb, M. R., Stadler, F. J., Yazdi, M. K., Nasirinezhad, M., Mohebbi, S., Seidi, F., Ganjali, M. R., & Mozafari, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000526 · Cited by 56
Macaraniag, C., Luan, Q., Zhou, J., & Papautsky, I. (2022) · APL Bioengineering · doi:10.1063/5.0093806 · Cited by 49
Youn, J., Hong, H., Shin, W., Kim, D., Kim, H. J., & Kim, D. S. (2022) · Biofabrication · doi:10.1088/1758-5090/ac4dd7 · Cited by 49
“Moreover, though the conventional drying methods usually require a substantial amount of time ( ∼ 10 h) for the preparation of an ECM membrane [30, 31, 35], the present in situ fabrication technique significantly reduced the fabrication time to ∼ 30 min.”
Self-citationOrgan‐on‐a‐Chip Systems for Women's Health Applications
Nawroth, J. C., Rogal, J., Weiß, M., Brucker, S. Y., & Loskill, P. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700550 · Cited by 47
Cell migration in microengineered tumor environments
Um, E., Oh, J. M., Granick, S., & Cho, Y. (2017) · Lab on a Chip · doi:10.1039/c7lc00555e · Cited by 47
Evaluation and live monitoring of pH-responsive HSA-ZnO nanoparticles using a lung-on-a-chip model
Meghani, N. M., Kim, K. H., Kim, S. H., Lee, S. H., & Choi, K. H. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01236-z · Cited by 50
Self-citationEngineering Breast Cancer On-chip—Moving Toward Subtype Specific Models
Moccia, C., & Haase, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.694218 · Cited by 51
Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
Quan, Y., Sun, M., Tan, Z., Eijkel, J. C. T., van den Berg, A., van der Meer, A. D., & Xie, Y. (2020) · RSC Advances · doi:10.1039/d0ra05173j · Cited by 47
Alavijeh, A. A., Barati, M. A., Barati, M., & Dehkordi, H. A. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.043 · Cited by 45
In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ
Brock, E. J., Ji, K., Shah, S. K., Mattingly, R. R., & Sloane, B. F. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9405-3 · Cited by 44
On-Chip Replication of Extremely Early-Stage Tumor Behavior
Li, C., Li, S., Du, K., Li, P., Qiu, B., & Ding, W. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c03740 · Cited by 40
Organs-on-Chips Platforms Are Everywhere: A Zoom on Biomedical Investigation
Zommiti, M., Connil, N., Tahrioui, A., Groboillot, A., Barbey, C., Konto‐Ghiorghi, Y., Lesouhaitier, O., Chevalier, S., & Feuilloley, M. G. J. (2022) · Bioengineering · doi:10.3390/bioengineering9110646 · Cited by 47
Carvalho, V. M., Bañobre‐López, M., Minas, G. M. H., Teixeira, S., Lima, R. A., & Rodrigues, R. O. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00224 · Cited by 44
Sacrificial Bioprinting of a Mammary Ductal Carcinoma Model
Duchamp, M., Liu, T., van Genderen, A. M., Kappings, V., Oklu, R., Ellisen, L. W., & Zhang, Y. S. (2019) · Biotechnology Journal · doi:10.1002/biot.201700703 · Cited by 37
Mammary Organoids and 3D Cell Cultures: Old Dogs with New Tricks
Sumbal, J., Budková, Z., Traustadóttir, G. Á., & Koledova, Z. S. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09468-x · Cited by 45
“Microfluidics has been useful in studies on various aspects of mammary cell and breast cancer biology, such as cell migration [30], cell-ECM interaction [31], or cell-cell interaction [32], as well as in drug screening [33, 34].”
MethodSubtype-specific characterization of breast cancer invasion using a microfluidic tumor platform
Moon, H., Ospina-Muñoz, N., Noe-Kim, V., Yang, Y., Elzey, B. D., Konieczny, S. F., & Han, B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234012 · Cited by 42
Advanced Devices for Tumor Diagnosis and Therapy
Wang, L., Dai, C., Jiang, L., Tong, G., Xiong, Y., Khan, K., Tang, Z., Chen, X., & Zeng, H. (2021) · Small · doi:10.1002/smll.202100003 · Cited by 39
Three‑dimensional models to study breast cancer (Review)
Huerta‐Reyes, M., & Aguilar‐Rojas, A. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5176 · Cited by 39
“This chip was able to recapitulate the general aspects of the mammary duct and of ductal mammary carcinoma, and also allowed the study of anticancer drugs and their effects on proliferation and invasion (57).”
BackgroundEngineering cell heterogeneity into organs-on-a-chip
Mertz, D. R., Ahmed, T., & Takayama, S. (2018) · Lab on a Chip · doi:10.1039/c8lc00413g · Cited by 33
Zeng, X., Ma, Q., Li, X., You, L., Li, J., Fu, X., You, F., & Ren, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1205157 · Cited by 39
“Such as prostate cancer, liver cancer, and breast cancer, to anti-tumor drugs (Choi et al., 2015; Riahi et al., 2016; Heninger et al., 2021) to identify candidate biomarkers of drug sensitivity and resistance.”
BackgroundAdvances in tumor-endothelial cells co-culture and interaction on microfluidics
Li, W., Khan, M., Mao, S., Feng, S., & Lin, J. (2018) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.07.005 · Cited by 37
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
“The model also examined the contribution of the TME to the progression of breast ductal carcinoma and evaluated the efficacy and toxicity of the drug paclitaxel on tumor growth [57].”
BackgroundMicrofluidic chip and its application in autophagy detection
Wang, X., Liu, Z., Fan, F., Hou, Y., Yang, H., Meng, X., Zhang, Y., & Ren, F. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.05.043 · Cited by 33
Wu, Y., Zhou, Y., Qin, X., & Liu, Y. (2021) · Biomicrofluidics · doi:10.1063/5.0062697 · Cited by 37
Organ-on-Chip platforms to study tumor evolution and chemosensitivity
Dsouza, V. L., Kuthethur, R., Kabekkodu, S. P., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188717 · Cited by 38
Abolhassani, H., Eskandari, A., Poor, A. S., Zarrabi, A., Khodadadi, B., Karimifard, S., Sahrayi, H., Bourbour, M., & Yaraki, M. T. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215754 · Cited by 36
Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays
Wang, X., Scarfò, I., Schmidts, A., Toner, M., Maus, M. V., & Irimia, D. (2019) · Advanced Science · doi:10.1002/advs.201901829 · Cited by 29
Kalot, R., Mhanna, R., & Talhouk, R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108156 · Cited by 31
Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients
Khorsandi, D., Yang, J., Foster, S., Khosravi, S., Kouchehbaghi, N. H., Zarei, F., Lee, Y. B., Runa, F., Gangrade, A., Voskanian, L., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302331 · Cited by 34
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing
Perucca, A., Gómez‐Llonín, A., Benach, O. M., Hallopeau, C., Rivas, E. I., Linares, J., Garrido, M., Sallent-Aragay, A., Golde, T., Colombelli, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56275-1 · Cited by 45
“8 The authors speculated that “treatments may modulate NK cell ability to adhere to cancer cells”, but their quantification methodology did not test this hypothesis.”
Organ-on-a-Chip systems for new drugs development
Vargas, R., Medina, L., & Egurbide, A. (2021) · ADMET & DMPK · doi:10.5599/admet.942 · Cited by 35
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
Tan, M. L., Lu, L., & Fischbach, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113852 · Cited by 32
Amir, S., Arathi, A., Reshma, S. C., & Mohanan, P. V. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123784 · Cited by 34
Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma
DePalma, T. J., Sivakumar, H., & Skardal, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114067 · Cited by 33
Park, S. M., Eom, S., Hong, H., Yoon, J., Lee, S. J., Kim, B. C., Kim, H. W., & Kim, D. S. (2018) · Microelectronic Engineering · doi:10.1016/j.mee.2018.10.010 · Cited by 31
Self-citationMammary gland 3D cell culture systems in farm animals
Finot, L., Chanat, E., & Dessauge, F. (2021) · Veterinary Research · doi:10.1186/s13567-021-00947-5 · Cited by 34
Metadata
- Authors
- Choi, Y., Hyun, E., Seo, J., Blundell, C., Kim, H. C., Lee, E., Lee, S. H., Moon, A., Moon, W. K., & Huh, D.
- Affiliations
- Department of Radiology, Seoul National University Hospital, Seoul, 110-744, Republic of Korea
- Seoul National University (KR)
- University of Pennsylvania (US)
- Duksung Women's University (KR)
- Corresponding author
- Moon, Woo Kyung
- Huh, Dongeun
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 15
- Issue
- 16
- Pages
- 3350-3357
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC4524879
- OpenAlex
- W2132922452
- Cited by
- 222
- References
- 24
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 28 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 24 · 2019: 17 · 2018: 19 · 2017: 15 · 2016: 12 · 2015: 3
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1DP2HL127720-01)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- early breast cancer, breast cancer microenvironment, ductal carcinoma in situ, tumor microenvironment, tumor spheroids, microfluidics, co-culture, mammary fibroblasts, drug screening, paclitaxel, extracellular matrix, tumor progression
- MeSH terms
- Antineoplastic Agents, Phytogenic, Breast Neoplasms, Carcinoma, Cell Survival, Cells, Cultured, Extracellular Matrix, Female, Humans, Models, Biological, Paclitaxel, Genes, Reporter, Cell Culture Techniques, Mammary Glands, Human, Microfluidic Analytical Techniques, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.